Single Arm, Exploratory and Open Clinical Trial of Second-line Therapy With Apatinib Mesylate in Advanced Cholangiocarcinoma
Latest Information Update: 05 May 2020
At a glance
- Drugs Rivoceranib (Primary)
- Indications Cholangiocarcinoma
- Focus Therapeutic Use
- 14 May 2018 New trial record